Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412768![]() (N-(3-fluoropyridin-4-yl)-5-methyl-2-(6-methylpyrid...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.25 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412735![]() (2-(6-(difluoromethyl)pyridin-2-yl)-N-(3-fluoropyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.25 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412743![]() (N-(3-fluoropyridin-4-yl)-2-(pyridin-2-yl)-7H-pyrro...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.260 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412766![]() (N-(4-((2-(6-(difluoromethyl)pyridin-2-yl)-7H-pyrro...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.370 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412738![]() (2-(pyrrolidin-1-yl)-N-(4-((2-(6-(trifluoromethyl)p...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.420 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412739![]() (2-(4-methylpiperazin-1-yl)-N-(4-((2-(6-(trifluorom...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.530 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412745![]() (N-(3-fluoropyridin-4-yl)-2-(6-(trifluoromethyl)pyr...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | Purchase MCE PDB UniChem | PDB US Patent | n/a | n/a | 0.560 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412773![]() (N-methyl-N-{2-[6-(trifluoromethyl)pyridin-2-yl]-7H...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412746![]() (2-(5-fluoro-6-methylpyridin-2-yl)-N-(3-fluoropyrid...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.600 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412775![]() (3-chloro-N-{2-[6-(trifluoromethyl)pyridin-2-yl]-7H...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.600 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412747![]() (2-(6-(difluoromethyl)pyridin-2-yl)-4-(1H-pyrrolo[3...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.640 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412774![]() (3-(trifluoromethyl)-N-{2-[6-(trifluoromethyl)pyrid...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.640 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412755![]() (N-(4-((2-(6-(trifluoromethyl)pyridin-2-yl)-7H-pyrr...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.670 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412734![]() (N-(3-fluoropyridin-4-yl)-2-(6-methylpyridin-2-yl)-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | Purchase UniChem | US Patent | n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412751![]() (N-(4-((2-(6-(difluoromethyl)pyridin-2-yl)-7H-pyrro...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.710 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412759![]() (N-(4-((2-(6-(trifluoromethyl)pyridin-2-yl)-7H-pyrr...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.740 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412778![]() (N-[4-({2-[6-(difluoromethyl)pyridin-2-yl]-5-{[(2-h...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.75 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412752![]() (US10399987, Example 17 | methyl (4-((2-(6-(difluor...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.760 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412741![]() (2-(6-(difluoromethyl)pyridin-2-yl)-N-(3-fluoropyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.760 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412764![]() (N-(4-((2-(5-fluoro-6-methylpyridin-2-yl)-7H-pyrrol...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.770 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412767![]() (2-morpholino-N-(4-((2-(6-(trifluoromethyl)pyridin-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.770 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412736![]() (N-(4-((2-(6-(difluoromethyl)pyridin-2-yl)-7H-pyrro...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.780 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412781![]() (N-[2-(5-fluoro-6-methylpyridin-2-yl)-7H-pyrrolo[2,...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.790 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412762![]() (3-methyl-N-(4-((2-(6-(trifluoromethyl)pyridin-2-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.850 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412772![]() (3-methyl-N-{2-[6-(trifluoromethyl)pyridin-2-yl]-7H...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.870 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412776![]() (N-[4-({2-[6-(trifluoromethyl)pyridin-2-yl]-7H-pyrr...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.870 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412756![]() (N-(4-((2-(pyridin-2-yl)-7H-pyrrolo[2,3-d]pyrimidin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412749![]() (2-(5-fluoropyridin-2-yl)-N-(3-fluoropyridin-4-yl)-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 0.910 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412780![]() (N-[2-(5-fluoro-6-methylpyridin-2-yl)-7H-pyrrolo[2,...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412757![]() (N-(4-((2-(6-methylpyridin-2-yl)-7H-pyrrolo[2,3-d]p...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412744![]() (2-(pyridin-2-yl)-4-(1H-pyrrolo[3,2-c]pyridin-1-yl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412753![]() (N-(5-fluoro-4-((2-(5-fluoro-6-methylpyridin-2-yl)-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412770![]() (1-(((2-(6-(difluoromethyl)pyridin-2-yl)-4-((3-fluo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412782![]() (N-(4-{[2-(5-fluoro-6-methylpyridin-2-yl)-7H-pyrrol...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412760![]() (N-(4-((2-(6-(difluoromethyl)pyridin-2-yl)-5-methyl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412771![]() (N-[3-fluoro-4-({2-[6-(trifluoromethyl)pyridin-2-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412777![]() (3-methoxy-N-{2-[6-(trifluoromethyl)pyridin-2-yl]-7...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412784![]() (N-(6-{4-[(3-chloropyridin-4-yl)amino]-7H-pyrrolo[2...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412765![]() (US10399987, Example 30 | methyl (4-((2-(6-(trifluo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412779![]() (N-[4-({2-[6-(difluoromethyl)pyridin-2-yl]-5-{[(2-h...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412761![]() (3,3-dimethyl-N-(4-((2-(6-(trifluoromethyl)pyridin-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412742![]() (2-(6-(difluoromethyl)pyridin-2-yl)-N-(3-fluoropyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412748![]() (N-(2-chloro-5-fluoropyridin-4-yl)-2-(5-fluoro-6-me...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412783![]() (N-(6-{4-[methyl(pyridin-4-yl)amino]-7H-pyrrolo[2,3...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412769![]() (N-(3-fluoropyridin-4-yl)-5-methyl-2-(6-(trifluorom...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412758![]() (N-(4-((2-(5-(trifluoromethyl)pyridin-2-yl)-7H-pyrr...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-1 [4-503,T204D] (Homo sapiens (Human)) | BDBM412754![]() (1-(4-((2-(6-(difluoromethyl)pyridin-2-yl)-7H-pyrro...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 5.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-2 (Homo sapiens (Human)) | BDBM412782![]() (N-(4-{[2-(5-fluoro-6-methylpyridin-2-yl)-7H-pyrrol...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-2 (Homo sapiens (Human)) | BDBM412756![]() (N-(4-((2-(pyridin-2-yl)-7H-pyrrolo[2,3-d]pyrimidin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TGF-beta receptor type-2 (Homo sapiens (Human)) | BDBM412752![]() (US10399987, Example 17 | methyl (4-((2-(6-(difluor...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myer Squibb Company US Patent | Assay Description Assays are conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or HIS-TGFβR2 WT, anti-HIS detec... | US Patent US10399987 (2019) BindingDB Entry DOI: 10.7270/Q2222X4N | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 98 total ) | Next | Last >> |